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The sea anemone, Nematostella vectensis, has the ability to fully regenerate amputated body 
parts. We hypothesize that Runx, a transcription factor, controls the cellular processes for 
regeneration, specifically the transition between cellular proliferation and cellular differentiation. 
A known inhibitor to the Runx pathway is Ro5-3335, a benzodiazepine. Inhibiting the Runx 
pathway by Ro5-3335 will help determine if Runx is necessary for proper regeneration in 
Nematostella. We introduced bisected Nematostella polyps to Ro5-3335 for a 24-48 period and 
observed regeneration of oral ends. Tentacle regeneration appeared delayed in treated polyps 
compared to the controls. It was not until three weeks post-treatment that the treated animals 
recovered normal regeneration. We conclude that Ro5-3335 appears to repress regeneration in 





The sea anemone, Nematostella vectensis, is a member of the cnidarian clade Anthozoa. They 
are burrowing anemones found in estuarine habitats with brackish waters (Reitzel et al., 2007). 
Nematostella are diploblastic with an outer and inner epithelial layer. Within their transparent 
body column are mesenteries that facilitate digestion. At one end of the body column is the 
physa, a rounded aboral structure used to burrow into the sand. The oral end, which includes the 
pharynx and tentacles, remains exposed to the water for feeding (Amiel et al., 2015). 
Nematostella is gaining increasing recognition as a model organism for developmental and 
genomic research due to the completion of its sequenced genome and the ability to spawn the 
animals in the laboratory (Reitzel et al., 2007).  
 
Nematostella are capable of regeneration. Regeneration is thought to occur via epimorphosis, a 
mechanism in which cells proliferate to regenerate the lost body part. During this process a 
cluster of undifferentiated cells form the blastema at the site of injury before differentiation and 
patterning of cells. Almost immediately after bisection, wound healing starts “with the edges of 
the wound site coming together.” For Nematostella, differentiation of cells typically occurs 
between 36 and 48 hours after bisection (Passamaneck and Martindale, 2012). 
 
Runx is a family of transcription factors known to be involved in the regulatory mechanism of 
cell proliferation and differentiation, especially during development in metazoans (Coffman, 
2003). When Runx heterodimerizes with CBFβ, “a non-DNA binding beta subunit,” the DNA 
binding affinity of Runx is enhanced (Coffman, 2009). In adult Nematostella, Runx and CBFβ 
shows high expression in overlapping regions of the head and tentacles (Sullivan et al., 2008). 
Mammals have three Runx genes that are also involved in developmental processes (Sullivan et 
al., 2008). However, mutations in mammalian Runx can be oncogenic or tumor suppressive 
(Coffman, 2009). The Nematostella Runx gene (Nv-runx) is 93% similar to RUNX1 in humans. 
Nv-runx also has a characteristic sequence that is conserved in protostomes and deuterostomes.  
 
Ro5-3335, a benzodiazepine, is known to interact with the Runx/CBFβ complex. The drug was 
developed to “block HIV gene expression by inhibiting Tat-mediated transactivation” in HIV 
patients (Cunningham et al., 2012). However, the drug has also been identified as an inhibitor to 
CBF leukemia in zebrafish models.  Ro5-3335 does not completely disrupt the 
heterodimerization between RUNX1-CBFβ, but “changes the conformation of their complex or 
increases the distance between RUNX1 and CBFβ in the complex” to inhibit their functions 
(Cunningham et al., 2012). The MCSFR (macrophage colony-stimulating factor receptor) 
promoter is activated by Runx/CBFβ. However, the activation of the promoter is significantly 
reduced in the presence of Ro5-3335 (Cunningham et al., 2012). 
 
This study investigates the inhibition of Runx by Ro5-3335 and its effect on regeneration of oral 
ends of Nematostella. We hypothesize that Nematostella treated with Ro5-3335 will only be able 
to wound heal insofar as forming a blastema and differentiation into regenerated body parts will 




MATERIALS AND METHODS 
ANIMAL CARE 
The Nematostella were kept in filtered seawater (12ppt) at room temperature. For the first 24-48 
hours, the polyps were kept in wells of microtiter plates with varying concentrations of Ro5-
3335, DMSO, and seawater (see below). After treatment the polyps were transferred to glass 
dishes with seawater that were covered to prevent evaporation. Menthol crystals were used to 
relax the Nematostella prior to bisection and before capturing images. Nematostella were fed 
using hatched brine shrimp. After treatment, relaxation, or feeding, the polyps had a change in 
seawater. 
 
PREPARATION AND TREATMENT 
The experiment was conducted with adult polyps, and they were bisected transversely across the 
oral/aboral axis using a scalpel. All cuts were made below the pharynx, at approximately the 
same location on each polyp. Each aboral end retained some presence of mesenteries. Once all 
the cuts were made, the aboral fragments were placed into the wells of a microtiter plate with 
seawater, varying concentrations of Ro5-3335 (0.5µM, 5µM, 25µM, and 50µM in DMSO). All 
animals were exposed to the drug for 24 hours (except for the 50µM concentration, where some 
were exposed for 48 hours). The control consisted of eighteen polyps which were only treated 
with seawater and 25µL of DMSO (the same amount of DMSO found in the 50uM treatment). 
There were eight polyps for all concentrations of inhibitor, except the solution with 50µM of 




DEVELOPMENTAL AND FUNCTIONAL OBSERVATIONS 
The polyps were observed at least once daily for a period of seven days following exposure to 
the drug. For 10 of the polyps treated for 48 hours in 50µM of Ro5-3335 (see above), we also 
exposed the regenerating animals to brine shrimp and observed for the ability to feed. Images 





To observe the effect of Ro5-3335 on Nematostella regeneration, we looked for regeneration of 
the oral end, including development of the mouth and pharynx and tentacle growth. Although 
tentacle growth was not quantified, qualitative observations were made.  After one day, the 
polyps appeared to have wound healing. After three days, all of the control polyps show signs of 
tentacle regeneration. By contrast, only some of the treated polyps displayed tentacle buds (Fig. 
1). After four days, polyps from each concentration all had tentacle growth (Fig. 2), but the 
tentacles were shorter compared to controls. After seven days, polyps from each concentration of 
Ro5-3335 treatment showed regeneration of tentacles (Fig. 3). However, many of the polyps 
displayed tentacles that were stubbier compared to the tentacles of the control.  
 
FUNCTIONAL OBSERVATIONS 
A feeding assay was conducted to see if the tentacles were fully operative following 
regeneration. For this assay, there were ten polyps for the control, and ten polyps that underwent 
treatment in 50µM Ro5-3335. The feeding sessions lasted between thirty minutes to one hour to 
allow for all polyps to have a chance to exhibit ingestion. Two days after treatment, three 
controls ate while no treatments ate. Four days after treatment, all ten controls exhibited 
tentacles, and seven were able to ingest the brine shrimp. For the ten 50µM Ro5-3335 treated 
polyps, nine showed tentacles, and only two ate (Table 1). 
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Fig. 1. Tentacle development three days after treatment. A. A control polyp. B. A polyp from 




Fig. 2. (C-F) Tentacle development four days after treatment. From left to right: control, 0.5µM, 







Fig. 3. (G-K) Tentacle growth on polyps seven days after treatment. Although regenerated, the 













Runx is thought to be involved in the transition between cell proliferation and differentiation 
during development and regeneration (Coffman, 2003). Ro5-3335 is known to be an inhibitor to 
Runx, so we wanted to see if Ro5-3335 has any effect on regeneration in Nematostella.  Our 
study shows that Ro5-3335 treatment does not completely inhibit regeneration, but that it does 
slow down the process. Differentiation and patterning normally occurs after 36-48 hours 
(Passamaneck and Martindale, 2012), but our observations indicate that treated animals took 
approximately 72 hours to regenerate. Even though the tentacles on the control polyps exhibited 
more regeneration after seven days compared to polyps with Ro5-3335 treatment, they appeared 
to be thinner and shorter when compared to normal regenerating Nematostella. After twenty-
three days the treated polyps looked fully regenerated, likely due to the decreased effects of the 
drug. 
 
Our data shows that 0.5µM of Ro5-3335 is sufficient to temporarily repress the Runx pathway 
and delay regeneration. Because the low concentrations of inhibitor show no significant effect, 
we conducted a second trial in order to increase the sample size and produce a kill curve. When 
50µM of Ro5-3335 is used to treat the Nematostella, it does not demonstrate lethal effects but 
has an effect on tentacle function. 
 
The feeding assay was conducted to determine if treated Nematostella have fully functioning 
tentacles. After two days of 50µM treatment, zero treated polyps ate compared to thirty percent 
of the controls. Four days following treatment displayed more significant results. Ninety percent 
of controls ate while only twenty-two percent of the treatments ate. During the feeding assay, we 
noticed that the treated polyps were able to sense the brine shrimp but were unable to retract 
them with their tentacles for ingestion. This suggests that high concentrations of inhibitor have a 
significant effect on tentacle function and may underlie the production of nematocysts.   
 
Since we did not determine Nv-runx expression, it cannot be certain that Ro5-3335 inhibited Nv-
runx in the polyps. Our data indicate that Ro5-3335 causes a delay in complete and normal 
regeneration in Nematostella which can be due to inhibiting the transition between cell 
proliferation and differentiation that the Runx pathway is known to regulate. We also show that 
inhibiting Runx with Ro5-335 likely affects tentacle regeneration. A greater sample size is 
needed to validate the significance of our data, so the results of this study should be viewed as 
preliminary.  
 
The conservation of Runx among a range of species suggest that it plays vital roles in the 
transition between cell proliferation and cellular differentiation (Coffman, 2009). The function of 
Runx and its role in developmental signaling is not fully understood. Future research might focus 
on only regeneration of tentacles since that is a region with high expression of Runx. A 
comparison can also be done with Hydra. It is a species within the cnidarian phylum capable of 
regeneration. However, regeneration is mediated by morphallaxis for Hydra. Further research of 
Runx will help understand why it has been conserved after independent diversification and its 
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